Member News
Meeting the COVID-19 Challenge
Genomics has played an important role in the battle against COVID-19. Scientists around the world have brought forward a herculean effort to manage the outbreak and bring an end to… Read More
Member News
Bold Therapeutics’ BOLD-100 Effective In Vitro Against COVID-19 Variants
VANCOUVER, BC — Bold Therapeutics, a clinical-stage biopharmaceutical company developing BOLD-100, a first-in-class oncology and antiviral therapeutic, is announcing robust preclinical efficacy data against a wide range of COVID-19 variants. New in vitro research… Read More
Member News
Northview Congratulates Portfolio Company Perimeter Medical Imaging AI Inc. on FDA Breakthrough Device Designation
Northview Lifesciences would like to congratulate Perimeter on their FDA Breakthrough Device Designation for the Optical Coherence Tomography (OCT) Imaging System with ImgAssist AI. The OCT Imaging System offers real… Read More
Member News
Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference
VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the executive management team will participate in a fireside chat during… Read More
Member News
NervGen Pharma Receives Ethics Approval to Initiate Phase 1 Clinical Trial for NVG-291 Remains on Track to Dose First Subjects in Q2 2021
VANCOUVER, BC – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQX: NGENF) (“NervGen” or the “Company”), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative… Read More